Literature DB >> 15090615

The transcriptional response to Raf activation is almost completely dependent on Mitogen-activated Protein Kinase Kinase activity and shows a major autocrine component.

Almut Schulze1, Barbara Nicke, Patricia H Warne, Simon Tomlinson, Julian Downward.   

Abstract

The Raf protein kinases are major effectors of Ras GTPases and key components of the transcriptional response to serum factors, acting at least in part through the extracellular signal-regulated kinase/mitogen-activated protein kinase pathway. It has recently been suggested that Raf also may trigger other as yet uncharacterized signaling pathways. Here, we have used cDNA microarrays to dissect changes in gene expression induced by activation of inducible c-Raf-1 constructs in human mammary epithelial and ovarian epithelial cells. The majority of Raf-induced transcriptional responses are shown to be blocked by pharmacological inhibition of the Raf substrate mitogen-activated protein kinase kinase, indicating that potential mitogen-activated protein kinase kinase-independent Raf signaling pathways have no significant influence on gene expression. In addition, we used epidermal growth factor receptor inhibitory drugs to address the contribution of autocrine signaling by Raf-induced EGF family proteins to the Raf transcriptional response. At least one-half of the transcription induced by Raf activation requires epidermal growth factor (EGF) receptor function The EGF receptor-independent component of the Raf transcriptional response is entirely up-regulation of gene expression, whereas the EGF receptor-dependent component is an equal mixture of up- and down-regulation. The use of transcriptional profiling in this way allows detailed analysis of the architecture of signaling pathways to be undertaken.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15090615      PMCID: PMC452596          DOI: 10.1091/mbc.e03-11-0807

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  49 in total

Review 1.  Activators and target genes of Rel/NF-kappaB transcription factors.

Authors:  H L Pahl
Journal:  Oncogene       Date:  1999-11-22       Impact factor: 9.867

Review 2.  How do small GTPase signal transduction pathways regulate cell cycle entry?

Authors:  C Marshall
Journal:  Curr Opin Cell Biol       Date:  1999-12       Impact factor: 8.382

3.  The p42/p44 MAP kinase pathway prevents apoptosis induced by anchorage and serum removal.

Authors:  M Le Gall; J C Chambard; J P Breittmayer; D Grall; J Pouysségur; E Van Obberghen-Schilling
Journal:  Mol Biol Cell       Date:  2000-03       Impact factor: 4.138

4.  Raf-independent deregulation of p38 and JNK mitogen-activated protein kinases are critical for Ras transformation.

Authors:  Kevin Pruitt; Wendy M Pruitt; Graham K Bilter; John K Westwick; Channing J Der
Journal:  J Biol Chem       Date:  2002-06-24       Impact factor: 5.157

5.  Growth factors from murine sarcoma virus-transformed cells.

Authors:  J E de Larco; G J Todaro
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

6.  Raf-1 promotes cell survival by antagonizing apoptosis signal-regulating kinase 1 through a MEK-ERK independent mechanism.

Authors:  J Chen; K Fujii; L Zhang; T Roberts; H Fu
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-26       Impact factor: 11.205

7.  The EGF receptor provides an essential survival signal for SOS-dependent skin tumor development.

Authors:  M Sibilia; A Fleischmann; A Behrens; L Stingl; J Carroll; F M Watt; J Schlessinger; E F Wagner
Journal:  Cell       Date:  2000-07-21       Impact factor: 41.582

8.  Raf induces NF-kappaB by membrane shuttle kinase MEKK1, a signaling pathway critical for transformation.

Authors:  B Baumann; C K Weber; J Troppmair; S Whiteside; A Israel; U R Rapp; T Wirth
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-25       Impact factor: 11.205

9.  The forkhead transcription factor AFX activates apoptosis by induction of the BCL-6 transcriptional repressor.

Authors:  Tracy Tzu-Ling Tang; Donald Dowbenko; Amanda Jackson; Lisa Toney; David A Lewin; Alexander L Dent; Laurence A Lasky
Journal:  J Biol Chem       Date:  2002-01-02       Impact factor: 5.157

10.  Oncogenic K-Ras and basic fibroblast growth factor prevent Fas-mediated apoptosis in fibroblasts through activation of mitogen-activated protein kinase.

Authors:  H Kazama; S Yonehara
Journal:  J Cell Biol       Date:  2000-02-07       Impact factor: 10.539

View more
  23 in total

Review 1.  Signaling in cell differentiation and morphogenesis.

Authors:  M Albert Basson
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-06-01       Impact factor: 10.005

2.  An in vitro multistep carcinogenesis model for both HPV-positive and -negative human oral squamous cell carcinomas.

Authors:  Yusuke Zushi; Mako Narisawa-Saito; Kazuma Noguchi; Yuki Yoshimatsu; Takashi Yugawa; Nagayasu Egawa; Masatoshi Fujita; Masahiro Urade; Tohru Kiyono
Journal:  Am J Cancer Res       Date:  2011-08-18       Impact factor: 6.166

3.  Ultrasonic bioreactor as a platform for studying cellular response.

Authors:  Anuradha Subramanian; Joseph A Turner; Gaurav Budhiraja; Sanjukta Guha Thakurta; Nicholas P Whitney; Sai Siddhartha Nudurupati
Journal:  Tissue Eng Part C Methods       Date:  2012-09-24       Impact factor: 3.056

Review 4.  Therapeutic Advancements Across Clinical Stages in Melanoma, With a Focus on Targeted Immunotherapy.

Authors:  Claudia Trojaniello; Jason J Luke; Paolo A Ascierto
Journal:  Front Oncol       Date:  2021-06-10       Impact factor: 6.244

5.  Mapping the molecular determinants of BRAF oncogene dependence in human lung cancer.

Authors:  Luping Lin; Saurabh Asthana; Elton Chan; Sourav Bandyopadhyay; Maria M Martins; Victor Olivas; Jenny Jiacheng Yan; Luu Pham; Mingxue Michelle Wang; Gideon Bollag; David B Solit; Eric A Collisson; Charles M Rudin; Barry S Taylor; Trever G Bivona
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-03       Impact factor: 11.205

Review 6.  Targeting mitogen-activated protein kinase kinase (MEK) in solid tumors.

Authors:  Austin Duffy; Shivaani Kummar
Journal:  Target Oncol       Date:  2009-11-10       Impact factor: 4.493

7.  Network Architecture Predisposes an Enzyme to Either Pharmacologic or Genetic Targeting.

Authors:  Karin J Jensen; Christian B Moyer; Kevin A Janes
Journal:  Cell Syst       Date:  2016-02-24       Impact factor: 10.304

8.  Mutation of ERBB2 provides a novel alternative mechanism for the ubiquitous activation of RAS-MAPK in ovarian serous low malignant potential tumors.

Authors:  Michael S Anglesio; Jeremy M Arnold; Joshy George; Anna V Tinker; Richard Tothill; Nic Waddell; Lisa Simms; Bianca Locandro; Sian Fereday; Nadia Traficante; Peter Russell; Raghwa Sharma; Michael J Birrer; Anna deFazio; Georgia Chenevix-Trench; David D L Bowtell
Journal:  Mol Cancer Res       Date:  2008-11       Impact factor: 5.852

9.  An integrated genomic analysis of lung cancer reveals loss of DUSP4 in EGFR-mutant tumors.

Authors:  D Chitale; Y Gong; B S Taylor; S Broderick; C Brennan; R Somwar; B Golas; L Wang; N Motoi; J Szoke; J M Reinersman; J Major; C Sander; V E Seshan; M F Zakowski; V Rusch; W Pao; W Gerald; M Ladanyi
Journal:  Oncogene       Date:  2009-06-15       Impact factor: 9.867

10.  PI-3 kinase activity is necessary for ERK1/2-induced disruption of mammary epithelial architecture.

Authors:  Gray W Pearson; Tony Hunter
Journal:  Breast Cancer Res       Date:  2009-05-20       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.